Medical Foam Market by Form (Flexible, Rigid, Spray), Material (Polymers, Latex, Metals), Application (Bedding & Cushioning, Medical Packaging, Medical Devices & Components, Prosthetics & Wound Care), and Region - Global Forecast to 2028

Medical Foam Market by Form (Flexible, Rigid, Spray), Material (Polymers, Latex, Metals), Application (Bedding & Cushioning, Medical Packaging, Medical Devices & Components, Prosthetics & Wound Care), and Region - Global Forecast to 2028

The global medical foam market will rise from USD 33.0 billion in 2023 to USD 43.3 billion by 2028 at a CAGR of 5.6% from 2023 to 2028. This growth can be attributed to the increasing aging population, the shift from traditional wound care products, the rise in global health care products, and the growth of the implantable device sector.

“The bedding & cushioning segment is expected to hold the largest share of the medical foam market during the forecast period.”

The bedding & cushioning segment accounted for the largest share of the medical foam industry in 2022. Medical foam offers design flexibility, strength, and durability and is used in the construction of bedding & cushioning products such as mattresses, orthopedic supports, and pads. Medical foams have compression-relieving capabilities, which adapt to the patient’s body shape, thus providing comfort to patients. The growth of this segment can be attributed to the increase in the aging population and the rising construction of hospitals and medical centers across the globe.

“Flexible foam is expected to be the largest segment of the medical foam market during the forecast period.”

The flexible foam segment is expected to be the largest in volume, owing to properties such as softness, moisture resistance, high impact & mechanical properties. Flexible foams regain their original shape even after being deformed. This property makes them suitable for use in bedding & cushioning products for patients to provide them with maximum comfort and support. Moreover, due to the ability to absorb shock, flexible foams are used in the packaging of medical devices and prosthetics.

“Polymer segment is expected to lead the medical foam market during the forecast period.”

Based on material, the polymer segment is estimated to account for the largest share of the medical foam market in 2022 in terms of volume. The major types of polymer foam used in medical applications include polyurethane foam, polystyrene foam, polyolefin foam, and others. The growth of the polymer segment is due to the abundant availability, ease of manufacturing, and low cost compared to other materials. Foamed polymers possess properties such as low weight, heat preservation, sound absorption, biocompatibility, and excellent cushioning.

“Asia Pacific is projected to grow at the highest CAGR of the medical foam market during the forecast period.”

The Asia Pacific medical foam industry has been studied for China, Japan, India, Indonesia, and the Rest of Asia Pacific. The Asia Pacific region presents an attractive market for medical foam due to shifting demographics and the rise in healthcare facilities and spending. Key industry leaders like Sekisui Chemical Co., Ltd. and INOAC Corporation have established manufacturing plants, distribution networks, and sales offices in the Asia Pacific area, ensuring a steady supply of medical foam. These companies are also acquiring smaller firms and fabricators of medical foam in the region, contributing to market growth. Additionally, medical foam manufacturers from North America and Europe are expanding their presence in the Asia Pacific, fostering knowledge exchange between developed and emerging nations through active participation in various forums.

Breakdown of primary interviews for the report on the medical foam market

By Company Type – Tier 1 – 16%, Tier 2 –36%, and Tier 3 – 48%

By Designation – C-Level – 16%, D-Level Executives – 24%, and Others – 60%

By Region – North America – 24%, Europe – 36%, Asia Pacific – 20%, Middle East & Africa – 12% South America – 8%,

Some of the leading manufacturers of medical foam profiled in this report include The Dow Chemical Company (US), Sekisui Chemical Co., Ltd. (Japan), Huntsman Corporation (US), Trelleborg AB (Sweden), BASF SE (Germany), Recticel NV (Belgium), INOAC Corporation (Japan), UFP Technologies, Inc. (US), FXI Holdings, Inc. (US), Armacell International SA (Germany), Rogers Corporation (US), Freudenberg Group (Germany), and Molnlycke Health Care (Sweden).

Research Coverage

This report covers the medical foam market by foam, material, application, and region. It aims to estimate the market’s size and future growth potential across various segments. The report also includes an in-depth competitive analysis of the key market players, their profiles, and key growth strategies.

Reasons to Buy the Report:

The report is expected to help the market leaders/new entrants by providing them with the closest approximations of revenue numbers of the medical foam market and its segments. This report is also expected to help stakeholders understand the market’s competitive landscape better, gain insights to improve the position of their businesses, and make suitable go-to-market strategies. It also enables stakeholders to understand the market’s pulse and provides information on key market drivers, restraints, challenges, and opportunities.

The report provides insights on the following pointers:

Analysis of critical drivers (Rise in global healthcare expenditure), restraints (Fluctuations in raw material prices), opportunities (Rise in demand for sustainable packaging solutions in healthcare), and challenges (Stringent rules & regulations) influencing the growth of the medical foam market.

Product Development/Innovation: Detailed insights on upcoming technologies, research &

development activities in the medical foam market.

Market Development: Comprehensive information about lucrative markets – the report analyses

the medical foam market across varied regions.

Market Diversification: Exhaustive information about new products & services, untapped

geographies, recent developments, and investments in the medical foam market.

Competitive Assessment: In-depth assessment of market shares, growth strategies, and service

offerings of leading players like The Dow Chemical Company (US), Sekisui Chemical Co., Ltd. (Japan), Huntsman Corporation (US), Trelleborg AB (Sweden), BASF SE (Germany), Recticel NV (Belgium), INOAC Corporation (Japan), UFP Technologies, Inc. (US), FXI Holdings, Inc. (US), Armacell International SA (Germany), Rogers Corporation (US), Freudenberg Group (Germany), Molnlycke Health Care (Sweden), and among others in the medical foam market.